Bright Minds Biosciences (DRUG)'s 30-day implied volatility (IV30) was 78.2% at the close on November 2, 2026, up from 60.4% the day before, against a 52-week range of 49.8% to 77.6%. Its 20-day historical volatility was 91.3%.
Data as of November 2, 2026.